CSPC PHARMA News

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - mRNA RSV VACCINE (SYS6016) OBTAINS CLINICAL TRIAL APPROVAL

Jul 11 05:21 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Jul 11 05:17 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.

Jul 8 05:14 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ROXADUSTAT CAPSULES OBTAIN DRUG REGISTRATION APPROVAL

Jul 5 05:33 ET

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024

Jul 2 05:26 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ENLONSTOBART INJECTION OBTAINS CONDITIONAL MARKETING APPROVAL GRANTED BY NMPA

Jun 28 08:52 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PALBOCICLIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL

Jun 28 04:58 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Jun 26 05:03 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - FIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020) OBTAINS CLINICAL TRIAL APPROVAL

Jun 25 05:39 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Jun 25 04:46 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Jun 24 05:10 ET

CSPC PHARMA: NEXT DAY DISCLOSURES RETURNS

Jun 21 05:35 ET

CSPC PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024

Jun 3 05:15 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - OLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL

Jun 3 04:38 ET

CSPC PHARMA: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

May 29 05:10 ET

CSPC PHARMA: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

May 28 04:44 ET

CSPC PHARMA: RETIREMENT OF EXECUTIVE DIRECTORS, APPOINTMENT OF EXECUTIVE DIRECTORS AND CHANGE OF AUTHORISED REPRESENTATIVE

May 28 04:42 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - RECOMBINANT FULLY HUMAN ANTI-Beta Klotho MONOCLONAL ANTIBODY DRUG (JMT202) OBTAINS CLINICAL TRIAL APPROVAL

May 17 04:54 ET

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - PERAMIVIR INJECTION OBTAINS DRUG REGISTRATION APPROVAL

May 14 04:46 ET

CSPC PHARMA: NEXT DAY DISCLOSURE RETURN

May 3 04:24 ET